期刊文献+

咳嗽变异性哮喘(CVA)发作期间短期使用舒利迭的疗效观察

The observation on effect of Short-term Seretide during the onset of CVA
下载PDF
导出
摘要 目的:观察咳嗽变异性哮喘(CVA)发作期间短期使用舒利迭的疗效。方法:选取经治疗的咳嗽变异性哮喘(CVA)患者的100例,随机,双盲平均分为2组各50例,对照组患儿采用传统治疗方案治疗如止咳,解痉,有感染时抗炎治疗,治疗组短期使用舒利迭治疗,必要时抗感染治疗,比较二种治疗方法的效果。结果:治疗组有效率明显高于对照组,有显著差异性(P<0.05)。结论:短期使用舒利迭治疗CVA有效,提高了患者的生活质量,大大减轻了对患者身心的损害及家长不必要的经济损失,在已治疗的病例中未发现不良反应,值得推广。 Objective: To observe the effect of Short-term Seretide during the onset of CVA.Methods: The 100 CVA patients were divided into 2 groups randomly and double-blind,50 cases in each group,the Control Group were treated with conventional therapy,Including antitussive,antispasmodic,anti-inflammatory treatment,the Treatment Group were given Short-term Seretide,comparing the effect between two group.Results: The Treatment Group was significantly higher than the control group,there were significant differences(P 0.05).Conclusion: The treatment of CVA by Short-term Seretide improved the quality of life of patients effectively,greatly reducing physical and mental harm on patients and economic losses of parents,no adverse reactions were found during the treatment.It is worth promoting.
出处 《赣南医学院学报》 2012年第1期71-72,共2页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 舒利迭 咳嗽变异性哮喘(CVA) 发作期间 疗效观察 Seretide CVA attack effect
  • 相关文献

参考文献6

二级参考文献72

  • 1[2]Johnson M. The beta adrenoceptor. Am J Respir Crit Care Med,1998, 158: S146-153.
  • 2[3]Green SA, Spasoff AP, Coleman RA, et al. Sustained activation of a G protein-coupled receptor via ″anchored″ agonist binding.Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem, 1996, 271: 24029-24035.
  • 3[4]Mak JC, Nishikawa M, Barnes PJ.Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol, 1995, 268: 241-246.
  • 4[5]Baraniuk JN, Ali M, Brody D, et al. Glucocorticoids induce beta 2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med, 1997, 155: 704-710.
  • 5[6]Eickelberg O, Roth M, Lorx R, et al. Ligand-independent activation of the glucocorticoid receptor by beta 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem, 1999, 274: 1005-1010.
  • 6[7]Condemi JJ, Stanley G, Christopher K, et al. The addition of salmeterol of fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Ann Allergy Asthma Immunol, 1999, 82: 383-389.
  • 7胡亚美,江载芳.实用而科学[M].7版.北京:人民卫生出版社,2002:631-642.
  • 8Berthelot JM,Maugars Y.Role for suppressor T cells in the pathogenesis of auto immune diseases(including rheumato idarthritis)[J].Joint Bone Spine,2004,71(5):374-380.
  • 9Umetsu DT,Akbari O,Dekruyff RH.Regulatory T cells control the development of allergic disease and asthma[J].J Allergy ClinImmunol,2003,112(3):480-487.
  • 10Thompson C,Powrie F.Regulatory T cells[J].Curr Op in Pharmacol,2004,4(4):408-414.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部